Portfolio

Astroscreen

Using the latest machine learning techniques and human intelligence to detect astroturfing campaigns at 'Tweet Zero'.

Bloomsbury AI

The Bloomsbury AI team joined the London Team of Facebook.

Freeline

Freeline Therapeutics is a biopharmaceutical company focused on the development of liver-directed gene therapies. The Company will develop and commercialise gene therapies for bleeding and other debilitating disorders.

Hazy AI

Hazy AI automates the process of anonymizing data for companies that hold vast swathes of customer information.

Matr

Matr provides one-to-one tutoring services via a proprietary online platform and aims to connect lower cost, higher quality tutoring supply from developing countries to developed economies.

MediaGamma

MediaGamma is developing an enterprise grade reinforcement machine learning platform, delivering machine decisions in under 5 milliseconds for a new class of business problems.

MeiraGX

MeiraGTx is a vertically integrated, clinical stage gene therapy company. It has core capabilities in viral vector design and optimization and gene therapy manufacturing, as well as a potentially transformative gene regulation technology. 

Odin Vision

Odin Vision is developing the next generation of AI enabled applications for endoscopic procedures.

Orchard Therapeutics

Orchard Therapeutics is a biotechnology company dedicated to bringing transformative gene therapies to patients with serious and life-threatening orphan diseases. It is a spin-out from the Institute of Child Health (ICH) at UCL.

Quell Therapeutics

Quell has been established with the aim of developing engineered T regulatory cell therapies. Quell will seek to utilise the power of Treg cells to advance therapies for the management and treatment of a range of solid organ transplant and autoimmune conditions.